Clinical Trials Directory

Trials / Completed

CompletedNCT03015116

Photobiomodulation for Plantar Fasciitis

Effectiveness of Photobiomodulation Compared to Usual Care for Plantar Fasciitis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
114 (actual)
Sponsor
Landstuhl Regional Medical Center · Federal
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

BACKGROUND: Plantar fasciitis, a degenerative injury of the connective tissue in the foot, results in pain-related disability in Service Members and beneficiaries and contributes to decreased physical activity and excessive healthcare costs. Even if effective, current treatment protocols may require 6-12 months of therapy to return individuals to pain-free activity. Photobiomodulation (PBM), or low level laser therapy, uses non-ionizing light to elicit biological changes in tissues resulting in beneficial therapeutic outcomes. Evidence supports use of PBM for other degenerative connective tissue conditions, such as Achilles tendinopathy and epicondylitis. Unfortunately, previous studies of PBM for treatment of plantar fasciitis lack optimized treatment parameters and therefore have been inconclusive on its clinical effectiveness. SPECIFIC AIMS: 1. Establish feasibility of and adherence to a photobiomodulation protocol in conjunction with and compared to usual care for plantar fasciitis treatment. 2. Assess the clinical effectiveness of photobiomodulation in conjunction with and compared to usual care to improve function and decrease pain and in patients. 3. Assess the difference between two photobiomodulation dose parameters in conjunction with and compared to usual care for plantar fasciitis treatment. DESIGN: The investigators will use a prospective randomized controlled trial to meet the aims of this exploratory study. METHOD: A sample of 114 military healthcare beneficiaries will be randomly assigned to either usual care, usual care plus PBM lower dose, or usual care plus PBM higher dose groups. At baseline, during the treatment protocol, and at long term (3 and 6 month) follow-up, measures of foot function and pain will be collected for analysis. The proposed methods will allow the study team to establish if PBM accelerates recovery compared to usual care, as well as determining the optimal dose for future trials comparing PBM to other, more invasive, therapies for plantar fasciitis.

Conditions

Interventions

TypeNameDescription
OTHERStretchingDaily foot and ankle stretching protocol
OTHERCryotherapyDaily cryotherapy in conjunction with stretching
DEVICEPhotobiomodulation Low PowerPhotobiomodulation treatment with 10W power output
DEVICEPhotobiomodulation High PowerPhotobiomodulation treatment with 25W power output

Timeline

Start date
2017-01-12
Primary completion
2018-10-31
Completion
2020-02-28
First posted
2017-01-09
Last updated
2021-09-21
Results posted
2021-09-21

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03015116. Inclusion in this directory is not an endorsement.